A new study by researchers at Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center has shown that in middle-aged individuals, there is a significant association between levels of SLIT2 protein in both vitreous humor (the gel-like substance in the eye) and plasma (blood) and neurocognitive test scores. This is the first study to report relative concentrations of SLIT2 in vitreous and plasma and establish an association between SLIT2 levels from both sources with cognitive function.

In a new study, researchers sought to gain a more thorough understanding of how participants of interorganizational collaborations can identify expertise that could be leveraged toward their organizations’ independent goals. Their findings, highlighting the importance of stability of the people involved (not just stability of the participating organizations), can inform the work of interorganizational health care alliances.

The Icahn School of Medicine at Mount Sinai has been awarded a $3.32 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) to study a new artificial intelligence (AI)-based tool that has the potential to predict cardiovascular event risk and treatment response among individuals with obstructive sleep apnea (OSA). The findings from this study could help clinicians make more informed recommendations about OSA treatment for their patients.